RT Conference Proceedings
T1 BRCA2men: An international, multicentre, observational and ambispective study to validate the predictive value of germline BRCA2 mutations for selecting the first-line of treatment in metastatic castration-resistant prostate cancer (mCRPC)
A1 Cattrini, C.
A1 Lozano Mejorada, R.
A1 Conteduca, V.
A1 Ruiz-Vico, M.
A1 Lolkema, M. P.
A1 Lorente, D.
A1 Sandhu, S.
A1 Romero Laorden, N.
A1 Loriot, Y.
A1 Azad, A. A.
A1 Costa, L.
A1 Vinceneux, A.
A1 Kanesvaran, R.
A1 Urun, Y.
A1 Puente, J.
A1 Attard, G.
A1 Mehra, N.
A1 De Giorgi, U.
A1 Olmos Hidalgo, D.
A1 Castro Marcos, E.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/26933
UL https://hdl.handle.net/10668/26933
LA en
DS RISalud
RD Apr 12, 2025